Tokyo Tape
Sign in
← SymBio Pharmaceuticals

Annual report

4582.TEDINET S100T3FG
Period2023-01-01 → 2023-12-31
Filed2024-03-22
StandardJapan GAAP
ConsolidatedYes
Data checks23 of 23 passed
Key figures · 114
MetricValuePeriodScopeSource row
Revenue¥5.6bn2023-01-01 → 2023-12-31Cons.Net sales
Revenue¥10.0bn2022-01-01 → 2022-12-31Cons.Net sales
Operating income−¥812m2023-01-01 → 2023-12-31Cons.Operating income
Operating income¥2.0bn2022-01-01 → 2022-12-31Cons.Operating income
Ordinary income−¥736m2023-01-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥2.0bn2022-01-01 → 2022-12-31Cons.Ordinary income
Profit before tax−¥1.2bn2023-01-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥2.1bn2022-01-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)−¥2.0bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.2bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income−¥2.0bn2023-01-01 → 2023-12-31Cons.Profit loss
Net income¥1.2bn2022-01-01 → 2022-12-31Cons.Profit loss
Total assets¥8.2bnat 2023-12-31Cons.Assets
Total assets¥10.4bnat 2022-12-31Cons.Assets
Total liabilities¥960mat 2023-12-31Cons.Liabilities
Total liabilities¥1.9bnat 2022-12-31Cons.Liabilities
Net assets / equity¥7.2bnat 2023-12-31Cons.Net assets
Net assets / equity¥8.5bnat 2022-12-31Cons.Net assets
Net assets / equity¥6.7bnat 2021-12-31dCons.Net assets
Cash and deposits¥6.5bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥6.3bnat 2022-12-31Cons.Cash and deposits
Cash & equivalents¥6.5bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥6.3bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥3.9bnat 2021-12-31dCons.Cash and cash equivalents
Operating cash flow−¥195m2023-01-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.6bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥377m2023-01-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥47m2022-01-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Financing cash flow¥680m2023-01-01 → 2023-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥628m2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥-49.192023-01-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.22022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥29.772022-01-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Net assets per share¥164.32at 2023-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥204.83at 2022-12-31Cons.Net assets per share (5-year summary)
Equity ratio84.9%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio77.6%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
ROE14.6%2022-01-01 → 2022-12-31Cons.Rate of return on equity (5-year summary)
Employees109at 2023-12-31Cons.Number of employees
Employees122at 2022-12-31Cons.Number of employees
Revenue¥5.6bn2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥10.0bn2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥8.3bn2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥3.0bn2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥2.8bn2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Operating income−¥852m2023-01-01 → 2023-12-31StandaloneOperating income
Operating income¥2.0bn2022-01-01 → 2022-12-31StandaloneOperating income
Ordinary income−¥774m2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income¥2.0bn2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income¥1.0bn2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥4.6bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥4.4bn2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.2bn2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Profit before tax¥2.1bn2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Net income−¥2.0bn2023-01-01 → 2023-12-31StandaloneProfit loss
Net income¥1.2bn2022-01-01 → 2022-12-31StandaloneProfit loss
Net income¥2.0bn2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income−¥4.1bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income−¥4.4bn2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Total assets¥8.2bnat 2023-12-31StandaloneAssets
Total assets¥10.4bnat 2022-12-31StandaloneAssets
Total assets¥8.5bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥6.3bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥5.3bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥980mat 2023-12-31StandaloneLiabilities
Total liabilities¥1.9bnat 2022-12-31StandaloneLiabilities
Net assets / equity¥7.2bnat 2023-12-31StandaloneNet assets
Net assets / equity¥8.5bnat 2022-12-31StandaloneNet assets
Net assets / equity¥6.7bnat 2021-12-31dStandaloneNet assets
Net assets / equity¥4.7bnat 2020-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥4.4bnat 2019-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥6.3bnat 2023-12-31StandaloneCash and deposits
Cash and deposits¥6.3bnat 2022-12-31StandaloneCash and deposits
Cash & equivalents¥3.9bnat 2021-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.8bnat 2020-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.9bnat 2019-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥140m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥4.1bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥4.4bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥71m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥160m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥216m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥72m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.2bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥3.7bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-49.792023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥30.372022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥53.042021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-124.132020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-189.032019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥29.952022-01-01 → 2022-12-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥52.322021-01-01 → 2021-12-31dStandaloneDiluted earnings per share (5-year summary)
Net assets per share¥164.02at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥204.95at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥162.26at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥105.76at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥143.07at 2019-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio84.6%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio77.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio73.7%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio64.3%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio71.7%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE16.6%2022-01-01 → 2022-12-31StandaloneRate of return on equity (5-year summary)
ROE39.6%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued42,278,081at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued39,603,606at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued38,457,206at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued38,202,956at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued26,437,681at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees103at 2023-12-31StandaloneNumber of employees
Employees118at 2022-12-31StandaloneNumber of employees
Employees141at 2021-12-31dStandaloneNumber of employees
Employees127at 2020-12-31dStandaloneNumber of employees
Employees107at 2019-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 1
SegmentItemPeriodValue
Research And Development Manufacturing And Sales Of Pharmaceuticals Etc And Related Businessreportable segmentemployeesat 2023-12-31109 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,272
ItemContextValueUnit
Payments for issuance of common stock fin cfCurrentYearDuration-11538000JPY
Proceeds from issuance of common stock fin cfPrior1YearDuration662000000JPY
Proceeds from issuance of common stock fin cfCurrentYearDuration692400000JPY
Purchase of treasury stock fin cfPrior1YearDuration-2165000JPY
Purchase of treasury stock fin cfCurrentYearDuration-996000JPY
Proceeds from disposal of treasury stock fin cfPrior1YearDuration81000JPY
Proceeds from disposal of treasury stock fin cfCurrentYearDuration21000JPY
Net cash provided by used in financing activitiesPrior1YearDuration627985000JPY
Net cash provided by used in financing activitiesCurrentYearDuration680160000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YearDuration213710000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYearDuration125673000JPY
Net increase decrease in cash and cash equivalentsPrior1YearDuration2408809000JPY
Net increase decrease in cash and cash equivalentsCurrentYearDuration234452000JPY
Cash and cash equivalentsPrior2YearInstant3860106000JPY
Cash and cash equivalentsPrior1YearInstant6282554000JPY
Increase in cash and cash equivalents from newly consolidated subsidiary ccePrior1YearDuration13637000JPY
Increase in cash and cash equivalents from newly consolidated subsidiary cceCurrentYearDuration－JPY
Cash and cash equivalentsPrior1YearInstant6282554000JPY
Cash and cash equivalentsCurrentYearInstant6517007000JPY
Number of consolidated subsidiariesCurrentYearInstant1
Write downs of inventoriesPrior1YearDuration－JPY
Write downs of inventoriesCurrentYearDuration91439000JPY
Promotion expenses sgaPrior1YearDuration1481789000JPY
Promotion expenses sgaCurrentYearDuration937821000JPY
Directors compensations sgaPrior1YearDuration122418000JPY
Directors compensations sgaCurrentYearDuration130414000JPY
Payroll and allowances sgaPrior1YearDuration461895000JPY
Payroll and allowances sgaCurrentYearDuration446506000JPY
Retirement benefit expenses sgaPrior1YearDuration699000JPY
Retirement benefit expenses sgaCurrentYearDuration796000JPY
Research and development expenses sgaPrior1YearDuration2554799000JPY
Research and development expenses sgaCurrentYearDuration2638234000JPY
Research and development expenses included in general and administrative expenses and manufacturing cost for current periodPrior1YearDuration2554799000JPY
Research and development expenses included in general and administrative expenses and manufacturing cost for current periodCurrentYearDuration2638234000JPY
Cash and depositsPrior1YearInstant_NonConsolidatedMember6259561000JPY
Cash and depositsCurrentYearInstant_NonConsolidatedMember6276521000JPY
Accounts receivable tradePrior1YearInstant_NonConsolidatedMember2084915000JPY
Accounts receivable tradeCurrentYearInstant_NonConsolidatedMember913094000JPY
Merchandise and finished goodsPrior1YearInstant_NonConsolidatedMember293757000JPY
Merchandise and finished goodsCurrentYearInstant_NonConsolidatedMember231650000JPY
Semi finished goodsPrior1YearInstant_NonConsolidatedMember175170000JPY
Semi finished goodsCurrentYearInstant_NonConsolidatedMember－JPY
SuppliesPrior1YearInstant_NonConsolidatedMember452000JPY
SuppliesCurrentYearInstant_NonConsolidatedMember380000JPY
Advance payments tradePrior1YearInstant_NonConsolidatedMember252745000JPY
Advance payments tradeCurrentYearInstant_NonConsolidatedMember271516000JPY
Prepaid expensesPrior1YearInstant_NonConsolidatedMember209886000JPY
Prepaid expensesCurrentYearInstant_NonConsolidatedMember366524000JPY
Other caPrior1YearInstant_NonConsolidatedMember13224000JPY
Other caCurrentYearInstant_NonConsolidatedMember29607000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 23 of 23 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-12-31pass
balance sheet identitynon_consolidated 2022-12-31pass
balance sheet identitynon_consolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass